American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$769M |
| 2 |
Kenvue
KVUE
|
+$204M |
| 3 |
Entegris
ENTG
|
+$176M |
| 4 |
Merck
MRK
|
+$148M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$143M |
Top Sells
| 1 |
Nike
NKE
|
+$278M |
| 2 |
Visa
V
|
+$272M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$228M |
| 4 |
Allstate
ALL
|
+$188M |
| 5 |
Wingstop
WING
|
+$165M |
Sector Composition
| 1 | Technology | 25.16% |
| 2 | Financials | 13.26% |
| 3 | Healthcare | 12.3% |
| 4 | Consumer Discretionary | 12.01% |
| 5 | Industrials | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Clear Channel Outdoor Holdings
CCO
$651M
| $76.1K | ﹤0.01% |
+46,103
| New | +$76.1K |
|
2802
BioCryst Pharmaceuticals
BCRX
$1.66B
| $75.7K | ﹤0.01% |
14,899
| – | – |
|
2803
Upland Software
UPLD
$71.6M
| $75.2K | ﹤0.01% |
24,342
+2,119
| +10% | +$6.55K |
|
2804
Lantronix
LTRX
$174M
| $73.4K | ﹤0.01% |
+20,626
| New | +$73.4K |
|
|
SYRS
2805
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $72.9K | ﹤0.01% |
+13,624
| New | +$72.9K |
|
2806
Standard BioTools
LAB
$493M
| $71.5K | ﹤0.01% |
+26,383
| New | +$71.5K |
|
2807
Sabre
SABR
$738M
| $70.3K | ﹤0.01% |
29,067
+90
| +0.3% | +$218 |
|
2808
Quantum-Si Incorporated
QSI
$239M
| $63K | ﹤0.01% |
+31,982
| New | +$63K |
|
|
VINC
2809
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $59.7K | ﹤0.01% |
+589
| New | +$59.7K |
|
2810
BlackSky Technology
BKSY
$684M
| $58.8K | ﹤0.01% |
5,408
-64
| -1% | -$696 |
|
2811
Altice USA
ATUS
$1.12B
| $57.7K | ﹤0.01% |
22,124
+36
| +0.2% | +$94 |
|
2812
Oramed Pharmaceuticals
ORMP
$98.8M
| $57.2K | ﹤0.01% |
19,591
+301
| +2% | +$879 |
|
|
VTNR
2813
DELISTED
Vertex Energy, Inc
VTNR
| $56K | ﹤0.01% |
40,023
+2,174
| +6% | +$3.04K |
|
2814
Aldeyra Therapeutics
ALDX
$324M
| $55.1K | ﹤0.01% |
16,860
+4,107
| +32% | +$13.4K |
|
|
MAGN
2815
Magnera Corporation
MAGN
$393M
| $55K | ﹤0.01% |
+2,116
| New | +$55K |
|
2816
LivePerson
LPSN
$86M
| $54.2K | ﹤0.01% |
54,331
+6,897
| +15% | +$6.88K |
|
2817
Crexendo
CXDO
$204M
| $52.7K | ﹤0.01% |
+10,958
| New | +$52.7K |
|
2818
Sensus Healthcare
SRTS
$52.3M
| $52.7K | ﹤0.01% |
13,867
-1,708
| -11% | -$6.49K |
|
|
TUYA
2819
Tuya Inc
TUYA
$1.57B
| $51.1K | ﹤0.01% |
29,178
| – | – |
|
2820
SGHC Ltd
SGHC
$6.39B
| $48.4K | ﹤0.01% |
14,019
-27,142
| -66% | -$93.6K |
|
2821
GSI Technology
GSIT
$98M
| $47.4K | ﹤0.01% |
+13,937
| New | +$47.4K |
|
2822
OppFi
OPFI
$312M
| $47.1K | ﹤0.01% |
+18,854
| New | +$47.1K |
|
|
AMTD
2823
AMTD IDEA Group
AMTD
$97.9M
| $46.8K | ﹤0.01% |
26,417
| – | – |
|
2824
Noodles & Co
NDLS
$30.7M
| $45.4K | ﹤0.01% |
23,780
-24,051
| -50% | -$45.9K |
|
|
GAU
2825
Galiano Gold
GAU
$654M
| $44K | ﹤0.01% |
31,701
-1,265
| -4% | -$1.76K |
|